Antitrust Lawsuit Against OhioHealth: Implications for Healthcare Competition

In February 2026, the United States and the state of Ohio initiated legal action against OhioHealth, a healthcare provider accused of antitrust violations. The government alleges that OhioHealth's contracts with commercial payors include provisions obstructing the emergence of lower-cost insurance plans, thereby stifling competition.

On February 20, 2026, the U.S. Department of Justice’s Antitrust Division and the Ohio Attorney General filed a civil lawsuit in the Southern District of Ohio. The lawsuit charges OhioHealth with violating the Sherman Act and Ohio's Valentine Act, asserting that the provider used its market influence in Columbus to pressure insurers into agreeing to terms that inhibit the development of cost-effective health plans.

OhioHealth is accused of limiting payors' use of competitive mechanisms, aimed at enhancing healthcare affordability for patients. The contract clauses allegedly blocked the creation of budget-friendly plans with competing health systems, deterring hospitals from providing competitive pricing due to low patient volume. Additionally, this practice is said to have impeded new provider market entry and expansion.

The government argues that despite holding a 35% market share, OhioHealth exerts substantial control, essential for insurers offering competitive networks in Columbus and beyond. This legal challenge mirrors similar actions, such as the 2016 case against Atrium Health, which concluded with mandated contracting practice reforms.

Legal advisors from Morgan Lewis emphasize the importance of antitrust regulatory compliance for healthcare providers, offering guidance on navigating federal and state regulatory challenges.